SUVRETTA CAPITAL MANAGEMENT, LLC bought BNTC

December 18, 2025 · Form 4 insider transaction

SUVRETTA CAPITAL MANAGEMENT, LLC bought 8,700 shares of BENITEC BIOPHARMA INC at $11.24 per share, a transaction worth $97.8K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction

Acquired (buy-side)

8,700

Price

$11.24

Total value

$97.8K

InsiderSUVRETTA CAPITAL MANAGEMENT, LLC

RoleDirector, 10% owner

CompanyBENITEC BIOPHARMA INC (BNTC)

SecurityCommon stock, par value $0.0001 per share

Transaction codeP — Open-market purchase

Transaction dateDecember 18, 2025

Filing dateDecember 22, 2025

Shares owned after9,546,875

OwnershipIndirect

10b5-1 planNo

AmendedNo

Footnotes

Notes are included on Exhibit 99.1.; Notes are included on Exhibit 99.1.

View the original Form 4 on SEC EDGAR